Publications

In addition to offering a differentiated range of analyses and comprehensive services, it is important to us to keep you informed about new investigations and test methods. Regularly published Bioscientia publications support you in deciding which further diagnostic procedure complements and secures the clinical data.

Furthermore, it is one of our goals and our understanding of medical quality to make the advances in medicine available to our customers. Therefore, we actively work on the introduction of these advances into daily diagnostics and are involved in study projects with corresponding questions.

 

 

Internal and National Publications

Anti Mullerian Hormone (AMH) is an indicator of ovarian functional reserve
click here (Lab.bulletin 2/2008, published 1/2009)

Biotinidase Deficiency
click here (laboratory up-date 2/2002)

branched DNA
click here (laboratory up-date 1/2001)

BRCA1/2 analyses
click here (laboratory up-date 11/2006)

Calcitonin determination in nodular goitre – diagnostic investigations of medullary thyroid cancer
click here (Lab.bulletin, published 3/2009)

Calprotectin – A marker for the inflammatory bowel diseases
click here (laboratory up-date, 05/2004 published 5/2010)

Chronic myeloid leukemia (CML) – diagnostics and therapeutic monitoring
click here (Laboratory up-date 11/2007)

Clarification of hypertension – Diagnosis of primary hyperaldosteronism
click here (Lab.bulletin, published 03/2017)

Copeptin – Polyuria-polydipsia syndrome/Pituitary surgery/Traumatic brain injury
click here (Lab.bulletin, published 03/2017)

Cystic fibrosis
click here (laboratory up-date 10/2006)

Diagnosis and Management of Chronic Hepatitis B virus Infection
click here (Lab.update, published 1/2009)

First trimester screening
click here (laboratory up-date 11/2005)

Fluorescence in-situ hybridization (FISH) for B-CLL patients
click here (laboratory up-date 1/2007)

Hemoglobinopathies and Thalassemias
click here (laboratory up-date 11/2005)

Hereditary Breast and Ovarian Cancer
click here (laboratory up-date 11/2005)

Human genetics spectrum of analyses
click here (laboratory up-date 11/2005)

Inborn errors of metabolism
click here (laboratory up-date 11/2005)

Infertility
click here (laboratory up-date no 2, 10/2007)

Marker for the diagnosis of an insulin resistance
click here (Lab.bulletin 1/2008, published 11/2008)

Molecular genetic analyses
click here (laboratory up-date 12/2006)

Newborn Screening
click here (laboratory up-date 11/2005)

Newborn Screening for the early detection of inborn errors of metabolism
click here (Laboratory up-date, 2/2008)

Pancreatic Elastase 1 in Faeces
click here (laboratory up-date 12/2002)

Pharmacogenetics
click here (laboratory up-date 11/2005)

Prenatal chromosomal diagnosis
click here (Laboratory up-date, 12/2007)

Prenatal diagnosis
click here (laboratory up-date 11/2005)

Prenatal Risk Analysis
click here (laboratory up-date 5/2007)

Rapid prenatal diagnosis of aneuploidies
click here (laboratory up-date 11/2005)

Selective Screening for inborn errors of metabolism
click here (Laboratory up-date, 2/2008)

Von Hippel Lindau
click here (laboratory up-date 11/2005)

 

2010

Alberer M, Hoefele J, Bergmann C , Hartrampf S, Hilberath J, Pawlita I, Albert MH, Benz MR, Weber LT, Schmid I. Reduced Methotrexate Clearance and Renal Impairment in a Boy With Osteosarcoma and Earlier Undetected Autosomal Dominant Polycystic Kidney Disease (ADPKD).J Pediatr Hematol Oncol 2010.

Aller E, Jaijo T, van Wijk E, Ebermann I, Kersten F, García-García G, Voesenek K, Aparisi MJ, Hoefsloot L, Cremers C, Díaz-Llopis M, Pennings R, Bolz HJ, Kremer H, Millán JM. Sequence variants of the DFNB31 gene among Usher syndrome patients of diverse origin. Mol Vis. 2010 Mar 23;16:495-500.

Becker JU, Saez AO, Zerres K, Witzke O, Hoyer PF, Schmid KW, Kribben A, Bergmann C , Nürnberger J. The mTOR pathway is activated in human autosomal-recessive polycystic kidney disease. Kidney Blood Press Res 33(2):129-38, 2010

Berger A, Gohl P, Stürmer M, Rabenau HF, Nauck M, Doerr HW. Detection and quantitation of HBV DNA in miniaturized samples: multi centre study to evaluate the performance of the COBAS ® AmpliPrep/COBAS ® TaqMan ® hepatitis B virus (HBV) test v2.0 by the use of plasma or serum specimens.J Virol Methods. 2010 Nov;169(2):404-8. Epub 2010 Aug 20.

Drenth JPH, Chrispijn M & Bergmann C . Congenital fibrocystic liver diseases. Best Pract Res Clin Gastroenterol 24: 573–584, 2010.

Ebermann I, Phillips JB, Liebau MC, Koenekoop RK, Schermer B, Lopez I, Schäfer E, Roux AF, Dafinger C, Bernd A, Zrenenr E, Claustres M, Blanco B, Nürnberg G, Nürnberg P, Ruland R, Westerfield M, Benzing T, Bolz HJ. PDZD7 is a modifier of retinal disease and a contributor to digenic Usher syndrome. J Clin Invest. 2010 Jun 1;120(6):1812-1823  >>>

Liu M, Shi S, Senthilnathan S, Yu J, Wu E, Bergmann C , Zerres K, Bogdanova N, Coto E, Deltas C, Pierides A, Demetriou K, Devuyst O, Gitomer B, Laakso M, Lumiaho A, Lamnissou K, Magistroni R, Parfrey P, Breuning M, Peters DJ, Torra R, Winearls CG, Genetic variation of DKK3 may modify renal disease severity in ADPKD. J Am Soc Nephrol 21(9):1510-20, 2010.

Ortiz Brüchle N, Venghaus A, von Bothmer J, Rudnik-Schöneborn S, Eggermann T, Bergmann C , Zerres K. Zystennieren – Eine Übersicht. Med Genet 2010

Otto EA, Hurd TW, Airik R, Chaki M, Zhou W, Stoetzel C, Patil SB, Levy S, Ghosh AK, Murga-Zamalloa CA, van Reeuwijk J, Letteboer SJ, Sang L, Giles RH, Liu Q, Coene KL, Estrada-Cuzcano A, Collin RW, McLaughlin HM, Held S, Kasanuki JM,..Bergmann C . Candidate exome capture identifies mutation of SDCCAG8 as the cause of a retinal-renal ciliopathy. Nat Genet 42(10):840-50, 2010.

Schild AM, Fricke J, Herkenrath P, Bolz H, Neugebauer A. Neuro-ophthalmological and ophthalmological findings in Joubert syndrome.Klin Monbl Augenheilkd 227: 786-791, 2010

Simon T, Feldkotter M, Buiting K, Ortmann M, Bolz H, Korber F. Slow progression of a small Wilms’ tumor. Klin Padiatr 222: 190-191, 2010

Striessnig J, Bolz HJ, Koschak A. Channelopathies in Cav1.1, Cav1.3, and Cav1.4 voltage-gated L-type Ca2+ channels. Pflugers Arch. 2010 Jul;460(2):361-74

Vester U, Kranz B & Bergmann C. Von Nierenzysten und Zystennieren. Päd Hautnah 2: 92-98, 2010.

Wilch E, Azaiez H, Fisher RA, Elfenbein J, Murgia A, Birkenhager R, Bolz H, Da Silva-Costa SM, Del Castillo I, Haaf T, Hoefsloot L, Kremer H, Kubisch C, Le Marechal C, Pandya A, Sartorato EL, Schneider E, Van Camp G, Wuyts W, Smith RJ, Friderici KH. A novel DFNB1 deletion allele supports the existence of a distant cis-regulatory region that controls GJB2 and GJB6 expression. Clin Genet 78: 267-274, 2010.

2009

Arndt T. Urine-creatinine concentration as a marker of urine dilution. Reflections using a cohort of 45000 samples.Forensic Sci Int 2009;186:48-51.

Arndt TGierten BGüssregen B B, Werle A, Grüner J. False-positive ethyl glucuronid screening associated with chloral hydrate medication as confirmed by LC-MS/MS and self-medication.Forensic Sci Int 2009;184:e27-29.

Bolz HJ. Genetik des Usher-SyndromsOphthalmologe 2009;106:496-504

Charbel Issa P, Bolz HJ, Ebermann I, Domeier E, Holz FG, Scholl HP. Characterisation of severe rod-cone dystrophy in a consanguineous family with a splice site mutation in the MERTK gene. Br J Ophthalmol. 2009 Jul;93(7):920-5

Ebermann I, Koenekoop RK, Lopez I, Bou-Khzam L, Pigeon R, Bolz HJ. An USH2A founder mutation is the major cause of Usher syndrome type 2 in Canadians of French origin and confirms common roots of Quebecois and Acadians. Eur J Hum Genet. 2009 Jan;17(1):80-4

Ebermann I, Wiesen MH, Zrenner E, Lopez I, Pigeon R, Kohl S, Löwenheim H, Koenekoop RK, Bolz HJ. GPR98 mutations cause Usher syndrome type 2 in males.J Med Genet. 2009 Apr;46(4):277-80.

Fischer DC, Jacoby U, Pape L, Ward CJ, Kuwertz-Bröcking E, Renken C, Nizze H, Querfeld U, Rudolph B, Müller-Wiefel DE, Bergmann C , Haffner D. Activation of the AKT/mTOR-pathway in autosomal recessive polycystic kidney disease (ARPKD).Nephrol Dial Transplant 24(6):1819-27, 2009.

Khanna H, Davis EE, Murga-Zamalloa CA, Estrada A, Lopez I, den Hollander AI, Zonneveld MN, Othman MI, Waseem N, Chakarova CF, Maubaret C, Diaz-Font A, MacDonald I, Muzny DM, Wheeler DA, Morgan M, Lewis LR, Logan CV, Tan PL, …Bergmann C ,… A common allele in RPGRIP1L is a modifier of retinal degeneration in ciliopathies. Nat Genet 41(6):739-45, 2009.

Mégarbané A, Slim R, Nürnberg G, Ebermann I, Nürnberg P, Bolz HJ. A novel VPS13B mutation in two brothers with Cohen syndrome, cutis verticis gyrata and sensorineural deafness.Eur J Hum Genet. 2009 Aug;17(8):1076-9

Senderek J, Garvey SM, Krieger M, Guergueltcheva V, Urtizberea A, Roos A, Elbracht M, Stendel C, Tournev I, Mihailova V, Feit H, Tramonte J, Hedera P, Crooks K, Bergmann C , Rudnik-Schöneborn S, Zerres K, Lochmüller H, Seboun E, Weis J, Beckmann JS. Autosomal-Dominant Distal Myopathy Associated with a Recurrent Missense Mutation in the Gene Encoding the Nuclear Matrix ProteinMatrin 3. Am J Hum Genet 84(4):511-8, 2009.

2008

Arndt TGuessregen B, Hallermann D, Nauck M, Terjung D, Weckesser H. Forensic analysis of carbohydrate-deficient transferrin by HPLC – statistics and extreme CDT values.Forens Sci Int 2008;175:27-30.

Arndt T, van der Meijden BB, Wielders JPM. Atypical serum transferrin isoform distribution in liver cirrhosis studied by HPLC, capillary electrophoresis and transferrin genotyping. Clin Chim Acta 2008;394:42-46.

Dittmar M, Knuth M, Beineke M, Epe B. Role of Oxidative DNA Damage and Antioxidative Enzymatic Defence Systems in Human AgingThe Open Anthropology Journal, 2008, 1, 38-45 >>>

Güssregen B B, Schröfel S, Nauck MArndt T. Selective Reaction Monitoring (SRM) Daten von mehr als 900 Xenobiotika für Aufbau uns Validierung von LC-MS/MS Analysen.Toxichem + Krimtech 2008;75:149-174. >>>

Jeppsson J-O, Arndt T, Schellenberg F, Wielders JPM, Anton RF, Whitfield JB, Helander A – International Federation of Clinical Chemistry and Laboratory Medicine Working Group on Standardization of Carbohydrate-deficient Transferrin (IFCC-WG-CDT). Standardization of CDT: Reply to the Letter by Tagliaro and Bortolotti in Clin Chem Lab Med 2008;46:727-728.

Zirn B, Steinberger D, Troidl C, Brockmann K von der Hagen M, Feiner C, Henke L, Müller U. Frequency of GCH1 deletions in Dopa-responsive dystonia.J Neurol Neurosurg Psychiatry 2008;79:183-186.  >>>

2007

Arndt T. Urin-Kreatininkonzentration: Kenngröße zur Prüfung auf Probenverwertbarkeit? Kritische Überlegungen aus ca. 25000 Urin-Kreatininbestimmungen in einem klinisch-chemischen Labor.Toxichem + Krimtech 2007;74:94-99.

Arndt T. Urin-Kreatininkonzentration: Kenngröße zur Prüfung auf Probenverwertbarkeit? Teil 2. Auswertung von ca. 20.000 Kreatinin-Analysen im Rahmen des Drogenscreenings.Toxichem + Krimtech 2007;74:155-158.

Arndt T, Erkens M, Holtkamp K, Keller T, Gressner AM. High prevalence of increased trisialotransferrin concentrations in patients with anorexia nervosa: implications for determination of carbohydrate-deficient transferrin. Clin Chim Acta 2007;379:150-153.

Arndt T, Stanzel S, Sewell AC. Paediatric age-dependent serum transferrin isoform distribution studied by HPLC. Clin Lab 2007;53:575-582.

Decker JWildhardt GSteinberger D. Molekulare Diagnostik beim von Hippel-Lindau-Syndrom.Hämato-Onkologische Nachrichten 2007:09-10:5.

Decker J. Hereditäre Nierentumoren – aktuelle Aspekte zur genetischen Beratung – medgen 2007;19:239-244.

Forzano F, Lituania M, Viassolo A, Superti-Furga V, Wildhardt G, Zabel B, Faravelli F. A familial case of achondrogenesis type II caused by a dominant COL2A1 mutation and “patchy” expression in the mosaic father.Am J Med Genet A. 2007;1431A(23):2815-2820. >>>

Gressner AM, Arndt T (Hrsg.). Lexikon der Medizinischen Laboratoriumsdiagnostik. Band 1 Klinische Chemie. 1411 Seiten, 745 Abb., 500 Tab., incl. CD-ROM, Springer, Heidelberg, 2007.

Jeppsson J-O, Arndt T, Schellenberg F, Wielders JPM, Anton RF, Whitfield JB, Helander A – International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Working Group on Standardization of Carbohydrate-deficient Transferrin. Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: I. AnalytClin Chem Lab Med 2007;45:558-562. >>>

Müller U, Zirn B, Steinberger D. Dopa-responsive dystonia (DRD). Encyclopedia of Molecular Mechanisms of Diseases, in press, edited by Florian Lang 2007, SPRINGER, Berlin ISBN: 3540334459

Sancken UKitschmann-Prawitt MSteinberger D. Integriertes und sequenzielles Screening: Neue Methoden der Risikoabschätzung fetaler Chromosomenanomalien. Frauenarzt 2007;48:38-43.

Sancken U. Nicht invasive Pränataldiagnostik. Deutsche Hebammen Zeitschrift 2007;4:19-22.

Steinberger DTrübenbach J, Zirn B, Leube B, Wildhardt G, Müller U. Utility of MLPA in deletion analysis of GCH1 in dopa-responsive dystonia. Neurogenetics 2007 Jan;8(1):51-55. Epub 2006 Nov 17 >>>

Tzschach A, Ramel C, Kron A, Seipel B, Wüster C, Cordes U, Liehr T, Hoeltzenbein M, Menzel C, Ropers HH, Ullmann R, Kalscheuer V, Decker JSteinberger D. Hypergonadotropic hypogonadism in a patient with inv ins(2;4).International Journal of Andrology 2007;30:1–5.  >>>

Zirn B, Steinberger D, Müller U. Dopa-responsive Dystonie: L-Dopa kompensiert erblichen BH4-Mangel. Der Neurologe und Psychiater 2007;4:54-56.

2006

Arndt T, Gressner A, Herwig J, Meier U, Sewell AC. Argininosuccinate lyase deficiency (ASL) and carbohydrate-deficient transferrin (CDT): Experience with four independent CDT analysis methods – misleading results given by the %CDT TIA assay. Clin Chim Acta 2006;373:117-120.

Arndt T, Keller T. Anorexia nervosa and carbohydrate-deficient transferrin. Psych Res 2006;144:245-246[Letter].

Arndt T, Meier U, Nauck M, Gressner A. Primary biliary cirrhosis is not a clinical condition for increased carbohydrate-deficient transferrin: Experience with four independent CDT analysis methods. Clin Chim Acta 2006;372:184-187.

Arndt T. Valid carbohydrate-deficient transferring testing (Letter to editor).Clinica Chimica Acta 2006;364:367-368.  >>>

Decker J. Von Hippel-Lindau-Syndrom.medgen 2006;18:355-361.

Frising M, Wildhardt G, Frisch L, Pitz S. Recurrent granular dystrophy of the cornea: an unusual case.Cornea 2006 Jun;25(5):614-7.  >>>

Hering A, Guratowska M, Bucsky P, Claussen U, Decker J, Ernst G, Hoeppner W, Michel S, Neumann H, Parlowsky T, Loncarevic I. Characteristic genomic imbalances in pediatric Pheochromocytoma.Genes, Chromosomes & Cancer 2006;45:602-607.  >>>

Reis J, John D, Heimeroth A, Mueller HH, Oertel WH, Arndt T, Rosenow F. Modulation of human motor cortex excitability by single doses of amantadine. Neuropsychopharmacology 2006;31:2758-66. >>>

Rett M, Held I, Peters U, Steinberger D, von der Wense A. Pränatale Diagnostik bei Apert-Syndrom. Monatszeitschrift Kinderheilkunde. Monatsschr Kinderheilkd 2006;154:903–906.

2005

Arndt TGuessregen BHohl AReis J.

Determination of serum amantadine by liquid chromatography-tandem mass spectrometry.Clin Chim Acta 2005;359:125-131. >>>

Arndt T. Kohlenhydrat-defizientes Transferrin.In: Thomas L (Hrsg.) Labor und Diagnose. TH-Books Verlagsgesellschaft mbH, Frankfurt, 6. Auflage, 2005:945-953.

Kaindl AM, Steinberger D, Heubner G, Mueller U, Blau N, Neubert K, Kunath B, von der Hagen M. Phenotype of five patients with Dopa-responsive Dystonia and mutations in GCH1. J Ped Neurol 2005;3:83-87.  >>>

Scheidhauer RGuessregen BHohl AArndt T. Effects of prolonged ambient storage of sodium fluoride/heparin specimens on plasma homocysteine. Clin Chem. 2005;51:1564-1565.

Wylenzek C, Trübenbach JGohl PWildhardt G, Alkins S, Fausett MB, Decker JSteinberger D. Mutation screening for the prothrombin variant G20210A by melting point analysis with the Light Cyclersystem: atypical results, detection of the variant C20209T and possible clinical implications. Clin Lab Haematol 2005;27(5):343-346.  >>>

2004

Arndt TGuessregen BHohl AHeicke B. Total plasma homocysteine measured by liquid chromatography-tandem mass spectrometry with use of 96-well plates. Clin Chem 2004;50:755-757.

Arndt T, Keller T. Forensic analysis of carbohydrate-deficient transferrin (CDT): Implementation of a screening and confirmatory analysis concept is hampered by the lack of CDT isoform standards. Forens Sci Int 2004;146:9-16.  >>>

Borck G, Topaloglu AK, Korsch E, Martine U, Wildhardt G, Onenli-Mungan N, Yuksel B, Aumann U, Koch G, Ozer G, Pfaffle R, Scherberg NH, Refetoff S, Pohlenz J. Four new cases of congenital secondary hypothyroidism due to a splice site mutation in the thyrotropin-beta gene: phenotypic variability and founder effect.J Clin Endocrinol Metab 2004 Aug;89(8):4136-41.

Mulliken JB, Gripp KW, Stolle CA, Steinberger D, Müller U. Molecular analysis of patients with synostotic frontal plagiocephaly (unilateral coronal synostosis).Plast Reconstr Surg. 2004 Jun;113(7):1899-909.  >>>

Nenoff P, Donaubauer K, Arndt T, Haustein U-F. Der Einfluss von Argininhydrochlorid auf den Harnstoffgehalt des Stratum corneum sowie die Hautfeuchtigkeit beim atopischen Ekzem und Altershaut.Hautarzt 2004;55:58-64 eingereicht.

Steinberger D, Blau N, Goriuonov D, Bitsch J, Zuker M, Hummel S, Müller U. Heterozygous mutation in 5`-untranslated region of sepiapterin reductase gene (SPR) in a patient with dopa-responsive dystonia. Neurogenetics. 2004 Sep;5(3):187-90. Epub 2004 Jul 6.  >>>

Zankl A, Zabel B, Hilbert K, Wildhardt G, Cuenot S, Xavier B, Ha-Vinh R, Bonafe L, Spranger J, Superti-Furga A. Sponyloperipheral dysplasia is caused by truncating mutations in the C-propeptide of COL2A1. Am J Med Genet A 2004;129(2):144-148.  >>>

2003

Arndt T. Asialotransferrin – An alternative to carbohydrate-deficient transferrin? Clin Chem 2003;49:1022-1023[Letter].  >>>

Borck G, Roth C, Martine U, Wildhardt G, Pohlenz J. Mutations in the PDS gene in German families with Pendred´s syndrome: V138F is a founder mutation.J Clin Endocrinol Metab 2003 Jun;88(6):2916-21.  >>>

Branson R, Potoczna N, Kral JG, Lentes KU, Hoehe MR, Horber FF. Binge eating as a major Phenotype of melanocortin 4 Receptor Gene Mutations.NEJM 2003;348(12):1096-1103.

de Bruijn H, Korzec A, Arndt T, van den Brink W. The discriminant validity of alcohol use disorder in well-functioning men with hazardous alcohol use.Eur Addict Res 2003;9:182-187.

Galban S, Fan J, Martindale JL, Cheadle C, Hoffman B, Woods MP, Temels G, Brieger J, Decker J, Gorospe M. von Hippel-Lindau protein-mediated repression of tumor factor alpha translation revealed through use of cDNA arrays. Molecular and Cellular Biology 2003;23(7):2316-2328.  >>>

Galban S, Martindale JL, Mazan-Mamczarz K, Lopez de Silanes I, Fan J, Wang W, Decker J, Gorospe M. Influence of the RNA-binding Protein HuR in pVHL-regulated p53 expression in renal carcinoma cells. Molecular and Cellular Biology 2003;23(20):7083-7090.  >>>

Naumann SDecker J. Genesis of variant Philadelphia chromosome translocations in chronic myelocytic leukemia. Cancer Genetics and Cytogenetics 2003;147:18-22.

Steinberger D, Reynolds DS, Ferris P, Lincoln R, Datta S, Stanley J, Paterson A, Dawson GR, Flint J.  Genetic mapping of variation in spatial learning in the mouse.J Neurosci. 2003 Mar 15;23(6):2426-33  >>>

2002

Arndt T, Kropf J. Alcohol abuse and carbohydrate-deficient transferrin analysis: Are screening and confirmatory analysis required? Clin Chem 2002;48:2072-2074[Letter].  >>>

Arndt T, Korzec A, Bär M, Kropf J. Further arguments against including trisialo-Fe2-transferrin in carbohydrate-deficient transferrin (CDT): a study on male alcoholics and hazardous drinkers. Med Sci Monit 2002;8:CR411-CR418.  >>>

Arndt T, Kropf J. A prolonged time interval between blood sample collection and centrifugation causes an increase in serum carbohydrate-deficient transferrin. Med Sci Monit 2002;8:BR61-BR64. >>>

Decker J, Brauch H. Nierenzellkarzinome.In: Nicht-hereditäre Tumorerkrankungen, Ganten D, Ruckpaul K (Eds.); Springer Verlag Berlin Heidelberg 2002;257-289

Müller U, Steinberger D, Topka H. Mutations of GCH1 in Dopa-responsive dystonia. J Neural Transm 2002 Mar;109(3):321-8  >>>

Préhu C, Behnken LJ, Neuman R, Riou J, Kister J, Kiger L, Promé D, Arndt T, Semmelroggen B, Schmidt M, Galactéros F, Wajcman H. A new unstable Hb variant with low oxygen affinity: Hb Ilmenau [ß41(C7)Phe®Cys]. Hemoglobin 2002;26:169-174.

Siegsmund M, Brinkmann U, Schäffeler E, Weireich G, Schwab M, Eichelbaum M, Fritz P, Burk O, Decker J, Alken P, Rothenpieler U, Kerb R, Hoffmeyer S, Brauch H. Association of the P-Glycoprotein Transporter MDR1 polymorphism with the suspectibility to renal epithelial tumors.J Am Soc Nephrol 2002; 13:1847-1854.  >>>

2001

Arndt T. Carbohydrate-deficient transferrin as a marker of chronic alcohol abuse: a critical review of preanalysis, analysis, and interpretation. Clin Chem 2001;47:13-27[Review].  >>>

Assmann B, Hackler R, Peters V, Schaefer JR, Arndt T, Mayatepek E, Jaeken J, Hoffmann GF. A new subtype of a congenital disorder of glycosylation (CDG) with mild clinical manifestations.Neuropediatrics 2001;32:313-318.

Cichutek A, Brückmann T, Seipel B, Hauser H, Schlaubitz S, Prawitt D, Hankeln T, Schmidt ER, Winterpacht A, Zabel B. Comparative architectural aspects of syntenic regions on human chromosome 11p15.3 and mouse chromosome 7 (including genes WEE1 and LMO1). Cytogenet Cell Genet 2001;93:277-283.

Groß U, Sassa S, Arndt T, Doss MO. Survival of two patients with severe d-aminolaevulinic acid dehydratase deficiency porphyria. J Inher Metab Dis 2001;24:60-64.  >>>

Naumann S, Reutzel D, Speicher M, Decker J. Complete karyotype charakterization of the K562 cell line by combined application of G-banding, multiplex-fluorescence in situ hybridization, fluorescence in situ hybridization, and comparative genomic hybridization. Leukemia Research 2001;25:313-322.  >>>

Nickelsen T, Creatsas G, Rechberger T, Depypere H, Erenus M, Quail D, Arndt T, Bonnar J. Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study. Climacteric 2001;4:320-331.

Niketeghad F, Decker J, Caselmann WH, Lund P, Geissler F, Dienes HP, Schirmacher P. Frequent genomic imbalances suggest commonly altered tumour genes in human hepatocarcinogenesis.British Journal of Cancer 2001;85(5):697-704.  >>>

Reutzel D, Mende M, Naumann S, Störkel S, Brenner W, Zabel B, Decker J. Genomic imbalances in 61 renal cancers from the proximal tubulus detected by comparative genomic hybridization.Cytogenet Cell Genet 2001;93:221-227.  >>>

2000

Adryan B, Decker J, Papas TS, Hsu T. Tracheal development and the von Hippel-Lindau tumor suppressor homolog in Drosophila. Oncogene 2000;19:2803-2811.  >>>

Arndt T, Pelzer M, Nenoff P, Pelzer S, Lindeke A, Steinmetz A, Haustein U-F. Lipoprotein- und Apolipoprotein-Elektrophorese bei X-chromosomal rezessiver Ichthyose. Hautarzt 2000;51:490-495.

Brauch H, Weirich G, Brieger J, Glavac D, Rödl H, Eichinger M, Feurer M, Weidt E, Puranakanitstha C, Neuhaus C, Pomer S, Brenner W, Schirmacher P, Störkel S, Rotter M, Masera A, Gugeler N, Decker J. VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation.Cancer Research 2000;60(4):1942-1948.  >>>

Brieger J, Weidt E, Decker J.
Fast, non-toxic, and inexpensive n-butanol preparation of recombinant plasmids.Genetics and Molecular Biology 2000;23(2):299-300.  >>>

Decker J, Schuler M. Internistische Onkologie: Grundlagen der internistischen Onkologie.Die Innere Medizin (hrsg. W. Gerog, Chr. Huber, Th. Meinertz, H. Zeidler) 10. Auflage Schattauer Verlag, S. 1223-42, Januar 2000

Hackler R, Arndt T, Helwig-Rolig A, Kropf J, Schaefer JR, Steinmetz A. Investigation by isoelectric focusing of the initial carbohydrate-deficient transferrin (CDT) and non-CDT transferrin isoform fractionation step involved in determination of CDT by the ChronAlcoI.D. assay. Clin Chem 2000;46:483-492.  >>>

Hess G, Reifenrath C, Friedrich-Freksa A, Beyer V, Naumann S, Schuch B, Huber C, Fischer T, Decker J. Autologous Transplantation of in vivo purged PBSC in CML : Comparison of FISH, Cytogenetics, and PCR detection of Philadelphia chromosome in Leukapheresis products. Cancer Genet Cytogenet 2000;117:1-8.  >>>

Nenoff P, Domel M, Arndt T, Haustein U-F. Staphylococcus aureus und bakterielle Toxine beim atopischen Ekzem vor und nach lokaler Glukokortikoid- und Teertherapie. Zeitschrift für Hautkrankheiten 2000;75:630-638.

1999

Adryan B, Carlguth V, Decker J. Digital image processing for rapid analysis of differentially expressed transcripts on high-density cDNA arrays.BioTechniques 1999;26:1174-1179. >>>

Arndt TBehnken LJ, Martens B, Hackler R. Evaluation of the cut-off for serum carbohydrate-deficient transferrin as a marker of chronic alcohol abuse determined by the ChronAlco I.D.™-Assay. J Lab Med 1999;23:507-510.

Brieger J, Weidt EJ, Gansen K, Decker J. Detection of a novel germline mutation in the von Hippel-Lindau tumor-suppressor gene by fluorescence-labelled base excision sequence scanning (F-BESS). Clin Genet 1999;56:210-215.  >>>

Brieger J, Weidt EJ, Schirmacher P, Störkel S, Huber C, Decker J. Inverse regulation of vascular endothelial growth factor and VHL tumor suppressor gene in sporadic renal cell carcinomas is correlated with vascular growth: an in vivo study on 29 tumors. J Mol Med 1999;77:505-510.

Schmidt L, Junker K, Nakaigawa N, Kinjerski T, Weireich G, Miller M, Lubensky I, Neumann H, Brauch H, Decker J, Vocke C, Brown J, Jenkins R, Richard S, Bergerheim U, Gerrard B, Dean M, Linehan WM, Zbar B. Novel mutations of the MET proto-oncogene in papillary renal carcinomas.Oncogene 1999;18:2343-2350.  >>>

1998

Arndt T, Czylwik D, Hackler R, Helwig-Rolig A, Gilg T. Carbohydrate-deficient transferrin is not affected by serum separators. Alcohol Alcoholism 1998;33:447-450.  >>>

Arndt T, Hackler R, Kleine TO, Gressner AM. Validation by isoelectric focusing of the anion-exchange isotransferrin fractionation step involved in determination of carbohydrate-deficient transferrin by the CDTect assay. Clin Chem 1998;44:27-34.  >>>

Arndt T, Hackler R. Evaluation of carbohydrate-deficient transferrin. Clin Chem 1998;44:1069 [Letter].  >>>

Arndt T, Kropf J, Brandt R, Gressner AM, Hackler R, Herold M, van Pelt J, Mårtensson O, Salzmann S, Velmans MH. CDTect-RIA and CDTect-EIA for determination of serum carbohydrate-deficient transferrin compared. Alcohol Alcoholism; 1998;33:639-645.

Wilke A, Hesse H, Kaiser A, Ferenczy I, Arndt T, Maisch B. Carbohydrate-deficient transferrin in patients with alcoholic cardiomyopathy.J Clin Bas Cardiol 1998;1:34-36.

1997

Arndt T, Hackler R, Müller T, Kleine TO, Gressner AM. Increased serum concentration of carbohydrate-deficient transferrin in patients with combined pancreas and kidney transplantation. Clin Chem 1997;43:344-351  >>>